#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diffuse large B-cell lymphoma recurrent Graft versus host disease Proteus syndrome Behcet's syndrome Immunodeficiency common variable Adrenocortical carcinoma Uterine leiomyosarcoma Malignant neoplasm of choroid Brain stem glioma Wiskott-Aldrich syndrome Immunodeficiency congenital Hereditary hypophosphataemic rickets Cortical dysplasia Arrhythmia Friedreich's ataxia More trials…

    Learn about Rare Diseases

    Haemophilia Idiopathic inflammatory myopathy – Life with Disease Soft tissue sarcoma – Diagnostics Basal cell naevus syndrome – Diagnostics Undifferentiated sarcoma – Basic Information Ewing’s sarcoma recurrent – Diagnostics Angiosarcoma recurrent – Diagnostics Mucopolysaccharidosis I – Treatment Pituitary-dependent Cushing’s syndrome – Trials in Disease Medulloblastoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olea Europaea Pollen Extract Ale.c04 Imlifidase Insulin Human (Rdna) Aspergillus Fumigatus Ravulizumab SEVABERTINIB Saruparib ALENDRONATE SODIUM TRIHYDRATE Grwd5769 Avatrombopag F510/08 Cefuroxime BW-20805 Sodium Zirconium Cyclosilicate IHMA-2121771-2 Tyra-300-B01 Nimorazole RUBIDIUM CHLORIDE Nimodipine More therapies…

    Learn about Your Condition

    Renal failure Apathy Microscopic polyangiitis Immune-mediated myositis Tertiary adrenal insufficiency Congenital pseudarthrosis Syphilis HER2 negative breast cancer Aortic disorder Anal squamous cell carcinoma Ventricular extrasystoles Pancreatitis chronic Postprandial hypoglycaemia KBG syndrome Castleman's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lupus nephritis

  • Study of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    • IgA nephropathy
    Investigated Drugs:
    • Ravulizumab
    France Germany Italy The Netherlands Poland Spain +1

  • Study on Anifrolumab for Adults with Active Lupus Nephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Anifrolumab
    Belgium Bulgaria France Germany Hungary Italy +2

  • Study on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy

    Not recruiting

    2 1
    Investigated Diseases:
    • Lupus nephritis
    • IgA nephropathy
    Investigated Drugs:
    • Vemircopan
    Germany Italy Spain

  • Study on the Safety and Effects of YTB323, Fludarabine Phosphate, and Tocilizumab in Patients with Severe, Refractory Systemic Lupus Erythematosus

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    France Germany Spain

  • Study on Zetomipzomib for Patients with Active Lupus Nephritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Water For Injection
    • Zetomipzomib
    • Methylprednisolone Sodium Succinate
    Croatia France Germany Greece Italy Portugal +1
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!